The stock of Innophos Holdings, Inc. (NASDAQ:IPHS) hit a new 52-week high and has $58.00 target or 25.00% above today’s $46.40 share price. The 7 months bullish chart indicates low risk for the $902.66 million company. The 1-year high was reported on Oct, 28 by Barchart.com. If the $58.00 price target is reached, the company will be worth $225.67 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 259,555 shares traded hands or 122.28% up from the average. Innophos Holdings, Inc. (NASDAQ:IPHS) has risen 41.59% since March 28, 2016 and is uptrending. It has outperformed by 36.88% the S&P500.
Analysts await Innophos Holdings, Inc. (NASDAQ:IPHS) to report earnings on November, 1. They expect $0.66 earnings per share, 0.00% or $0.00 from last year’s $0.66 per share. IPHS’s profit will be $12.84M for 17.58 P/E if the $0.66 EPS becomes a reality. After $0.61 actual earnings per share reported by Innophos Holdings, Inc. for the previous quarter, Wall Street now forecasts 8.20% EPS growth.
Innophos Holdings, Inc. (NASDAQ:IPHS) Ratings Coverage
Out of 2 analysts covering Innophos Holdings (NASDAQ:IPHS), 1 rate it a “Buy”, 1 “Sell”, while 0 “Hold”. This means 50% are positive. Innophos Holdings has been the topic of 3 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The stock of Innophos Holdings, Inc. (NASDAQ:IPHS) earned “Sell” rating by Zacks on Monday, August 24. Zacks downgraded Innophos Holdings, Inc. (NASDAQ:IPHS) on Thursday, September 3 to “Sell” rating. The firm earned “Buy” rating on Thursday, October 20 by Sidoti.
According to Zacks Investment Research, “Innophos, Inc., is one of the leading North American manufacturers of specialty phosphates, serving a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos’ market-leading positions derive from its experience and dedication to customer service and innovation.”
Insitutional Activity: The institutional sentiment decreased to 1.22 in 2016 Q2. Its down 0.15, from 1.37 in 2016Q1. The ratio is negative, as 14 funds sold all Innophos Holdings, Inc. shares owned while 53 reduced positions. 30 funds bought stakes while 52 increased positions. They now own 17.50 million shares or 0.21% more from 17.46 million shares in 2016Q1.
State Of Tennessee Treasury Department holds 0% or 15,618 shares in its portfolio. Ladenburg Thalmann Financial Services reported 1,492 shares or 0% of all its holdings. Bernzott Cap Advsrs holds 2.9% of its portfolio in Innophos Holdings, Inc. (NASDAQ:IPHS) for 351,442 shares. Tower Rech Capital (Trc) holds 39 shares or 0% of its portfolio. Paradigm Asset Mgmt Com Lc last reported 3,600 shares in the company. Axa has invested 0.01% of its portfolio in Innophos Holdings, Inc. (NASDAQ:IPHS). Kanaly Trust has 0% invested in the company for 145 shares. Blackrock Institutional Na, a California-based fund reported 481,071 shares. Ifrah Financial Services last reported 5,460 shares in the company. Hillsdale Invest Mngmt accumulated 0.18% or 14,250 shares. Voya Invest Limited Liability Corporation accumulated 0% or 9,882 shares. Piermont Capital Mngmt has invested 0.66% of its portfolio in Innophos Holdings, Inc. (NASDAQ:IPHS). Price T Rowe Assocs Md has 5,650 shares for 0% of their US portfolio. Amer Interest Group Incorporated last reported 0% of its portfolio in the stock. Millennium Mgmt Limited Liability Co holds 11,358 shares or 0% of its portfolio.
Insider Transactions: Since May 20, 2016, the stock had 2 buys, and 0 insider sales for $77,419 net activity. The insider Zatta Robert J bought $37,109.
More notable recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: Prnewswire.com which released: “Innophos Holdings, Inc. Reports Third Quarter 2016 Results” on October 27, 2016, also Prnewswire.com with their article: “Innophos Holdings, Inc. Appoints Joshua Horenstein As Chief Legal Officer And …” published on September 09, 2016, Prnewswire.com published: “Innophos Holdings, Inc. Reports Third Quarter 2015 Results” on November 03, 2015. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) were released by: Prnewswire.com and their article: “Innophos Holdings, Inc. Appoints Han Kieftenbeld As Chief Financial Officer” published on April 04, 2016 as well as Prnewswire.com‘s news article titled: “Innophos To Host Third-quarter 2016 Financial Results Conference Call On …” with publication date: October 13, 2016.
IPHS Company Profile
Innophos Holdings, Inc., incorporated July 15, 2004, is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Firm also provides bioactive mineral and nutritional ingredients. The Company’s divisions include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other. The Specialty Phosphates US & Canada segment and Specialty Phosphates Mexico segment comprises product lines, such as Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA), and Technical Grade Sodium Tripolyphosphate (STPP) & Detergent Grade PPA. The GTSP & Other segment includes fertilizer co-product Granular Triple Super Phosphate (GTSP) and other non-specialty phosphate products. The Specialty Phosphates US & Canada segment and the Specialty Ingredients product line includes the activities of Innophos Nutrition, Inc.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.